 |
|
  |
|
|
|
|
|
|
Item
|
Date
|
Currency
|
Patent Statute
Title 35 U.S.C.
|
November 2, 2002
|
P.L. 107-273
|
Trademark Statute
Title 15, Chapter 22 U.S.C
|
November 29, 1999
|
P.L. 106-113, the American Inventors Protection Act of 1999
|
37 C.F.R. Parts 1 and 41
(The Rules of Practice Before the United States Patent and Trademark Office, Parts 1 and 41)
|
February 20, 2008
|
Current through "Revision to the Time of Filing of a Biological Deposit and the Date of Availability of a Biological Deposit" (73 FR 9254-9259).
|
The Waxman-Hatch Act
(The Drug Price Competition and Patent Term Restoration Act of 1984 and Associated Regulations and Laws)
|
June 18, 2003
|
Statutes through P.L. 105-115 (FDA Modernization Act of 1997, November 21, 1997); Regulations through 68 Fed. Reg. 36775 (June 18, 2003) including FDA Guidance for Industry, 180-day exclusivity when multiple ANDAs are submitted on the same day July 31, 20
|
Federal Rules of Evidence
|
March 1, 2007
|
|
Federal Rules of Civil Procedure
|
March 1, 2007
|
|
|
|
|
NOTICE: While every effort was made to ensure the accuracy of the materials, this information is provided for the user's convenience only and is not guaranteed or warranted to be accurate. We recommend that users verify the accuracy of these help files before attempting to rely thereon
|
|
|
